Protesters in the USA against the launch in the country of the abortificient Mifegyne (mifepristone; aka RU 486) have identified products that are to be targeted for boycott by its supporters. The protesters have formed a coalition antiabortion group to focus their efforts.
Drugs to be boycotted that are manufactured by Hoechst Roussel include antiacne solution ATS (erythromycin) the antihypertensiv Altace (ramipril), the anti-infective Claforan (cefotaxime sodium), Lasix (ciclopirox) used to treat skin infections, Prokine (sargramostim), a white cell growth factor, and Topicort (desoximetasone), used to treat skin rashes.
Also on the boycott list are the following drugs from Copley: the decongestant antihistamine Bromatapp (brompheniramine maleate, phenylephrine HCl and phenylpropanolamine HCl), the sedative doxylamine succinate, the topical antifungal miconazole nitrate, and tolnaftate a solution for fungal skin infections.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze